Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Operating Expenses | 37,342 | 24,726 | 8,749 | 8,990 | 0 |
| Operating Income | -37,342 | -24,726 | -8,749 | -8,990 | N/A |
| Other Income | 2,255 | 1,559 | 232 | 0 | 0 |
| Pre-tax Income | -35,087 | -23,167 | -8,517 | -8,990 | 0 |
| Net Income Continuous | -35,087 | -23,167 | -8,517 | -8,990 | N/A |
| Net Income | $-35,087 | $-23,167 | $-8,517 | $-8,990 | $N/A |
| EPS Basic Total Ops | -18.40 | -22.60 | -142.10 | -265.60 | N/A |
| EPS Basic Continuous Ops | -18.39 | -22.57 | -142.19 | -265.98 | N/A |
| EPS Diluted Total Ops | -18.40 | -22.60 | -142.10 | -265.60 | N/A |
| EPS Diluted Continuous Ops | -18.39 | -22.57 | -142.19 | -265.98 | N/A |
| EPS Diluted Before Non-Recurring Items | -18.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-37,020 | $-24,512 | $-8,574 | $-8,836 | $N/A |